logo
Plus   Neg
Share
Email

Novartis Drug Revolade Improves Outcomes For ITP Patients

Novartis (NVS) announced results of a retrospective, real-world evidence study in patients with immune thrombocytopenia or ITP treated with Revolade or eltrombopag, compared to other second-line therapies. The data demonstrated that patients experienced better clinical outcomes with Revolade, in terms of fewer bleeding episodes.

The company noted that Revolade (eltrombopag) showed lower rate of bleeding-related episodes and similar rate of thrombotic events vs. romiplostim, rituximab and
splenectomy, in a retrospective analysis of US electronic health records.

The company said that the patients who received splenectomy, as second-line regimen, showed highest platelet counts and most frequent thrombotic event rates among groups receiving other therapies.

Immune thrombocytopenia (ITP) is a rare blood disorder where there is an increased risk of bleeding due to a low number of platelets.

For comments and feedback contact: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Southwest Airlines Co. said it will investigate whether a dispute with its mechanics union was the cause of an "unprecedented number" of out-of-service aircraft that resulted in flight cancellations and flight delays. Southwest Airlines COO Mike Van de Ven said in a statement that the airline has been negotiating with Aircraft Mechanics Fraternal Association or AMFA for more than six years. Shares of Air France-KLM Group were gaining around 4 percent in Paris trading after the airline reported Wednesday narrower net loss in its fourth quarter with improved revenues. For fiscal 2019, Air France-KLM Group plans to selectively grow capacity for the Passenger network by 2 percent to 3 percent compared to 2018. The company also said it will pursue initiatives to reduce unit costs. Walmart Inc. (WMT) reported adjusted EPS of $1.41 for the fourth-quarter of fiscal 2019. On average, 27 analysts polled by Thomson Reuters expected the company to report profit per share of $1.33 for the quarter. Analysts' estimates typically exclude special items. Net income attributable to Walmart...
Follow RTT